Biopharmaceuticals News Roundup: September 9, 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
HSMN NewsFeed,
9 Sep 2010:
Biopharmaceuticals, Licensing
[Shire plc, Acceleron Pharma, ACE-031, Duchenne Muscular Dystrophy]
|
Zyngenia, Inc. Raises $15 Million in Series A Extension Financing
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Venture Capital
[Zyngenia, Zybody]
|
iPierian Announces Second Close of $28 Million Series B Financing
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Regenerative Medicine, Venture Capital
[iPierian, stem cell]
|
Tekmira Pharmaceuticals Strengthens Management Team With Addition of Paul Brennan as Senior Vice President, Business Development
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Personnel
[Tekmira Pharmaceuticals, RNAi]
|
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's Treatment
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Neurology
[Curaxis Pharmaceutical, Memryte, Alzheimer's disease]
|
Rhythm Closes $40 Million Series A Financing
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Venture Capital
[Rythm Pharmaceuticals]
|
Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Pharmaceutical for Japan
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Oncology
[Onyx Pharmaceuticals, Ono Pharmaceutical, carfilzomib, ONX 0912]
|
Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Abbott, Piramal]
|
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
HSMN NewsFeed,
8 Sep 2010:
Biopharmaceuticals, Oncology
[Jennerex, Transgene, JX-594]
|
Bristol-Myers Squibb to Acquire ZymoGenetics
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Bristol-Myers Squibb, ZymoGenetics, Pegylated-Interferon, RECOTHROM, thrombin]
|
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, FDA
[Forest Laboratories, ceftaroline fosamil, community acquired bacterial pneumonia]
|
Watson's Generic Yasmin(R) Receives FDA Approval
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Generics, FDA
[Watson Pharmaceuticals, Zarah, drospirenone, ethinyl estradiol, Bayer, Yasmin]
|
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone(R) Litigation
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Generics, Litigation
[Teva Pharmaceutical, Sandoz, Copaxone, glatiramer, multiple sclerosis]
|
Cubist Pharmaceuticals Announces Promotion of Steven C. Gilman, Ph.D., to EVP, Research and Development and Chief Scientific Officer
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Personnel
[Cubist Pharmaceuticals, CUBICIN, daptomycin, lipopeptide]
|
James F. Szigethy Named Curemark's Director of New Product Development
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Neurology, Personnel
[Curemark]
|
La Jolla Pharmaceutical Company Provides Update on Search for Clinical Products to In-License or Acquire
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Licensing
[La Jolla Pharmaceutical, Riquent, lupus]
|
Watson Confirms Combigan(R) Patent Challenge
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Generics, Ophthalmology, Litigation
[Watson Pharmaceuticals, Brimonidine Tartrate, Timolol, Allergan, Combigan]
|
NeoStem Appoints Distinguished Businessman as New President and Managing Director NeoStem China
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Regenerative Medicine, Personnel
[NeoStem, stem cell]
|
Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Venture Capital
[Alethia Biotherapeutics, monoclonal antibody]
|
Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
HSMN NewsFeed,
7 Sep 2010:
Biopharmaceuticals, Personnel
[Protalix BioTherapeutics]
|
Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
HSMN NewsFeed,
3 Sep 2010:
Biopharmaceuticals, Oncology
[Celldex Therapeutics, Pfizer, Pfizer Vaccines, rindopepimut]
|
Gilead Sciences Submits European Marketing Application for Once-Daily Single-Tablet Regimen of Truvada(R) and TMC278 for the Treatment of HIV Infection
HSMN NewsFeed,
3 Sep 2010:
Biopharmaceuticals, HIV/AIDS
[Gilead Sciences, Tibotec Pharmaceuticals, Truvada]
|
Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
HSMN NewsFeed,
3 Sep 2010:
Biopharmaceuticals, Neurology, Licensing
[Ipsen, Santhera Pharmaceuticals, fipamezole, dyskinesia, Parkinson’s Disease]
|
Pfizer to Acquire FoldRx Pharmaceuticals
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Pfizer, FoldRx Pharmaceuticals]
|
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Venture Capital
[Celator Pharmaceuticals]
|
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Regulatory
[Archimedes Pharma, PecFent, fentanyl nasal spray, breakthrough cancer pain]
|
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Personnel
[Inspire Pharmaceuticals]
|
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
HSMN NewsFeed,
1 Sep 2010:
Biopharmaceuticals, Ophthalmology
[ThromboGenics, microplasmin, vitreomacular adhesion]
|
Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
HSMN NewsFeed,
31 Aug 2010:
Biopharmaceuticals, Ophthalmology, FDA
[Allergan, LUMIGAN, bimatoprost, intraocular pressure, glaucoma]
|
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
HSMN NewsFeed,
31 Aug 2010:
Biopharmaceuticals
[J&JPRD, Johnson & Johnson, rivaroxaban, venous thromboembolism, DVT]
|
Meda acquires Alaven, a US specialty pharma company
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Meda AB, Alaven]
|
Otonomy Closes $38.5 Million Series B Financing
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Venture Capital
[Otonomy]
|
King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Personnel
[King Pharmaceuticals]
|
Genzyme Confirms Receipt of Unsolicited Proposal
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Genzyme, Sanofi-Aventis]
|
Easton Pharmaceuticals Inc. Announces Experienced CFO Appointment to Management Team
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Personnel
[Easton Pharmaceuticals]
|
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
HSMN NewsFeed,
30 Aug 2010:
Biopharmaceuticals, Neurology
[Sanofi-aventis, multiple sclerosis, teriflunomide, TEMSO trial]
|
sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
HSMN NewsFeed,
29 Aug 2010:
Biopharmaceuticals, Mergers & Acquisitions
[sanofi-aventis, Genzyme]
|
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
HSMN NewsFeed,
27 Aug 2010:
Biopharmaceuticals, Cardiology, FDA
[Novartis Pharmaceuticals, aliskiren, amlodipine, Tekamlo]
|
Genentech Provides Update on FDA Application for T-DM1
HSMN NewsFeed,
27 Aug 2010:
Biopharmaceuticals, Oncology, FDA
[Genentech, Roche Group, trastuzumab-DM1, T-DM1, HER2, armed antibody]
|
|
<<
Older Biopharmaceuticals Stories
Current Newsfeed >>
|
Public
Feeds 
Full text >>